# Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes

> **NCT01908803** · PHASE2 · TERMINATED · sponsor: **Alcon Research** · enrollment: 84 (actual)

## Conditions studied

- Acute Otitis Media

## Interventions

- **DRUG:** AL-60371/AL-817 otic suspension
- **DRUG:** Ciprofloxacin 0.3%/dexamethasone 0.1% otic suspension

## Key facts

- **NCT ID:** NCT01908803
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 84 (ACTUAL)
- **Why stopped:** Management decision
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01908803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01908803, "Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01908803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*